Hedge Fund Perry Capital Bets On Paper Mills, Puerto Rico (Finalternatives) Perry Capital, the $10.9 billion hedge-fund firm run by Richard Perry, is...
Keep Reading →
July 25 - Hedge Funds - Comments
Zug, Switzerland-based Argentiere Capital is an alternative investment management firm, which was founded by Deepak Gulati. Mr. Gulati is a former head...
Keep Reading →
July 16 - Hedge Funds, News - Comments
In its filing with the Securities and Exchange Commission, Neal C. Bradsher’s Broadwood Capital has disclosed further reducing its stake in Questcor...
Keep Reading →
April 10 - Hedge Funds, News - Comments
The week that started on Feb. 17th saw several major hedge funds complete important transactions in the stock market. Let’s take a look at some of...
Keep Reading →
February 21 - Hedge Funds, News - Comments
Neal C. Bradsher‘s Broadwood Capital has trimmed its stake in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) by selling 20,000 shares. According to...
Keep Reading →
January 28 - Hedge Funds, News - Comments
If you were to cross a Bugatti Veyron with a McLaren F1 — two cars capable of reaching 60 mph in less than 3.2 seconds — you’d get a...
Keep Reading →
November 6 - News - Comments
Is Theravance Inc (NASDAQ:THRX) a good investment? At the moment, there are many indicators investors can use to analyze stocks. Some of the most under...
Keep Reading →
September 12 - News - Comments
Is Viropharma Inc (NASDAQ:VPHM) a good investment? If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era...
Keep Reading →
August 28 - News - Comments
Since Dendreon Corporation (NASDAQ:DNDN) reported its second-quarter earnings, the stock has declined 40%. Following the quarter, analysts from Wedbush...
Keep Reading →
August 28 - News - Comments
In today’s marketplace, there are dozens of gauges shareholders can use to watch stocks. A pair of the most innovative are hedge fund and insider trading...
Keep Reading →
August 27 - News - Comments
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading...
Keep Reading →
August 27 - News - Comments
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) investors: listen up. In today’s marketplace, there are a multitude of methods shareholders can use to watch...
Keep Reading →
August 27 - News - Comments
Here’s why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) might be a sell. Now, according to many market players, hedge funds are viewed as delayed,...
Keep Reading →
August 22 - News - Comments
It has been approximately a year since the Citron Research report about Questcor Pharmaceuticals Inc (NASDAQ:QCOR) came out, which caused the stock to...
Keep Reading →
August 21 - News - Comments
There has been a lot of talk here lately at StreetAuthority about selling options. And with good reason. When it’s done right, options can be one...
Keep Reading →
August 20 - News - Comments
One of the best income strategies in the world involves a “glitch” in the financial markets. It allows individual investors to generate...
Keep Reading →
August 19 - News - Comments
As human beings it can sometimes be difficult for us to see the good in a bad situation. In the biotech sector, where developing a drug can cost hundreds...
Keep Reading →
August 7 - News - Comments
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a safe stock to buy now? Hedge funds are turning bullish. The number of long hedge fund bets increased by...
Keep Reading →
August 6 - News - Comments
How would you like to make a 27%-plus return on your investment — within one week? Shareholders in three health-care companies enjoyed such gains...
Keep Reading →
August 5 - News - Comments
If you’re feeling good about the market, you’re not alone. Take my hand as we go over some of this week’s more uplifting headlines....
Keep Reading →
August 3 - News - Comments
I began using Motley Fool’s CAPS as a way to disclose when I purchased and sold stocks, and my 97.2 rating showcases my last 10 months. CAPS compares...
Keep Reading →
August 2 - News - Comments
As we do each month, we asked a handful of our top analysts across sectors for one stock that looks especially compelling right now. Here are the companies...
Keep Reading →
August 2 - News - Comments
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...
Keep Reading →
August 2 - Hedge Funds - Comments
Three months ago after Questcor Pharmaceuticals Inc (NASDAQ:QCOR) announced its first-quarter financial results, I asked if those results were as bad...
Keep Reading →
July 31 - News - Comments
What’s better than momentum? Mo’ momentum. Let’s take a closer look at five of this past week’s biggest scorchers. Company July...
Keep Reading →
July 29 - News - Comments
Despite some negative news, mainly related to reimbursement issues and excess stock booking, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) recently gained...
Keep Reading →
July 28 - News - Comments
Biotech is booming these days. But that’s not a new story by any means. Biotech stocks as a group have done very well over the past several years...
Keep Reading →
July 24 - News - Comments
Note: This article has been amended to remove the specifics of the Questcor investigation. Motley Fool apologizes for the error. Celgene Corporation (...
Keep Reading →
July 23 - News - Comments
Celgene Corporation (NASDAQ:CELG) fell 2.6% on Thursday after disappointing clinical data for its blood cancer drug Revlimid. Investors don’t appear...
Keep Reading →
July 22 - News - Comments
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) has a particularly fascinating history, having been at the center of controversy for the better part of its...
Keep Reading →
July 17 - News - Comments
For the last several years, certain stocks have remained cheap as the overwhelming presence of short sellers have made it more difficult for shares to...
Keep Reading →
July 12 - News - Comments
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some pharmaceutical stocks to...
Keep Reading →
July 2 - News - Comments
Which biotech companies are the best-run? That could be a difficult question to answer, since there are many perspectives on what constitutes a well-run...
Keep Reading →
June 24 - News - Comments
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Keep Reading →
June 17 - News - Comments
Investors in a handful of health-care stocks are probably all smiles this week. Several stocks saw nice double-digit gains over the past five days. Here...
Keep Reading →
June 17 - News - Comments
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) saw a 15% gain on Tuesday. The large gains occurred after the company acquired rights to develop the autoimmune...
Keep Reading →
June 13 - News - Comments
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...
Keep Reading →
June 12 - Hedge Funds - Comments
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case...
Keep Reading →
June 11 - News - Comments
Why try to beat ’em if you can just buy ’em? That’s the approach that Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is taking. The biotech...
Keep Reading →
June 11 - News - Comments
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was in 13 hedge funds’ portfolio at the end of the first quarter of 2013. ARNA investors should pay attention...
Keep Reading →
June 10 - News - Comments
Short-sellers certainly huffed and puffed with all of their might in May, but it wasn’t meant to be: The tech-heavy NASDAQ Composite (INDEXNASDAQ...
Keep Reading →
June 6 - News - Comments
Virtually every investor is quite familiar with the names of big pharmaceutical giants such as GlaxoSmithKline plc (ADR) (NYSE:GSK), Eli Lilly & Co...
Keep Reading →
May 30 - News - Comments
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) was in 26 hedge funds’ portfolio at the end of March. QCOR has experienced a decrease in support from...
Keep Reading →
May 30 - News - Comments
Health care stocks have soared in 2013. Does that mean that there aren’t good bargains still to be found for value investing fans? Not at all. Several...
Keep Reading →
May 16 - News - Comments
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds’ portfolio at the end of December. INFI has experienced an increase in enthusiasm...
Keep Reading →
May 9 - News - Comments
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) has faced the affects of bad press more than once in the past. The stock lost more than half of its value last...
Keep Reading →
May 8 - News - Comments
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a healthy stock for your portfolio? Money managers are taking a bullish view. The number of bullish hedge...
Keep Reading →
May 7 - News - Comments
Wall Street had a great week. The Dow topped 15,000. The S&P 500 also notched a record high. But few stocks blew the doors off like those of these...
Keep Reading →
May 4 - News - Comments
With earnings season in full-swing, and with countless large moving stocks, I am looking at four companies that reported earnings on Wednesday that I...
Keep Reading →
May 3 - News - Comments
Many believed that Q1 earnings would be the start of a larger trend higher that reversed the losses seen in shares of Questcor Pharmaceuticals, Inc. (...
Keep Reading →
May 3 - News - Comments